The battle to acquire Metsera an innovative US biotech firm specializing in obesity treatment took a dramatic turn On Thursday new bids were laid down intensifying the rivalry between pharma giants Pfizer and Novo Nordisk
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
